Spinal Cord Injuries: Clinical Trials

28 trials for Spinal Cord Injuries, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 6 recruiting, 5 not yet recruiting, 5 unknown. 28 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 128Completed 8, Recruiting 6, Not yet recruiting 5, Unknown 5, Active not recruiting 1, Enrolling by invitation 1, Terminated 1, Withdrawn 1

Follow Spinal Cord Injuries: new trials by email Literature Review of Spinal Cord Injuries trials Research Report on Spinal Cord Injuries

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardiocentric Inotropic Optimization in Spinal Cord Injury
Dobutamine crossover - SCI - Spinal Cord Injury
Early Phase 1Not yet recruitingUniversity of British Columbia82027-06-012026-10-13
NeuroRise: Intrathecal CE-1 Treatment for Traumatic SCI
Human allogeneic, culture expanded, UC-MSC - SCI - Spinal Cord Injury, SCI
Early Phase 1Not yet recruitingCell Therapy LLC82026-09-012026-07-31
Coupled Gentamicin-Lactobacillus Rhamnosus in NLUTD
Gentamicin, Lactobacillus Rhamnosus GG - Spinal Cord Injury, Neurogenic Bladder (NB)
Early Phase 1Not yet recruitingMedstar Health Research Institute482026-08-012026-08-21
Treatment of Spinal Cord Injury Using Autologous Concentrated Growth Factors
Concentrated Growth Factors (CGF) - Spinal Cord Injury
Early Phase 1Not yet recruitingThird Affiliated Hospital, Sun Yat-Sen University102025-12-012025-11-28
tESCS for Upper Limb Rehab in Spinal Cord Injury
Transcutaneous spinal cord stimulation (tESCS) active group, Sham transcutaneous spinal cord stimulation (tESCS) - Spinal Cord Injuries (SCI)
Early Phase 1Not yet recruitingNHS Greater Glasgow and Clyde202025-11-012025-10-06
Intravesical Lactobacillus Crispatus: Clinical Safety and Microbiome Evaluation
Lactobacillus Crispatus, Saline bladder wash - Spinal Cord Injuries (SCI), Neurogenic Bladder
Early Phase 1RecruitingMedstar Health Research Institute402025-09-092025-12-30
Allogeneic Cord Blood for Neurological Diseases in Adults
Allogeneic cord blood treatment - Neurological Diseases, Stroke
Early Phase 1WithdrawnThe Medical Pavilion Bahamas2025-07-012025-09-10
MEP Up-conditioning to Target Corticospinal Plasticity
Up-conditioning of the wrist extensor motor evoked potential - Spinal Cord Injury, Tetraplegia/Tetraparesis
Early Phase 1RecruitingMedical University of South Carolina112025-05-272026-03-30
Early BOTOX After Spinal Cord Injury
Bladder chemodenervation (Botox), Bladder Sham (Saline) Injection Procedure - Spinal Cord Injuries
Early Phase 1Enrolling by invitationUniversity of Washington102024-07-272026-09-09
Testosterone and Neural Function in Men With Spinal Cord Injury
Natesto testosterone intranasal gel, Ayr Saline Nasal Gel - Spinal Cord Injury
Early Phase 1RecruitingVA Office of Research and Development152024-04-012026-10-06
Neuromodulation to Reduce Muscle Stiffness Following Spinal Cord Injury
Transcutaneous spinal stimulation at 100 Hz, Transcutaneous spinal stimulation at 50 Hz, Transcutaneous spinal stimulation at 50 Hz and single dose of baclofen - Spinal Cord Injuries, Spinal Cord Injury
Early Phase 1UnknownUniversity of Mississippi Medical Center162024-03-012024-07-01
Can Brief Exposure to Hyperoxia Improve Function After Chronic Spinal Cord Injury?
Pure oxygen (99%) from Praxair, Edmonton, DIN# 02014408 - Spinal Cord Injuries
Early Phase 1RecruitingUniversity of Alberta252022-07-112026-09-11
High Frequency SARS for Neurogenic Bladder and Bowel Emptying
Finetech-Brindley Sacral Anterior Roots Stimulation System - Spinal Cord Injury
Early Phase 1CompletedVA Office of Research and Development42022-07-012025-08-22
Effects of 4-AP on Functional SCI Recovery
Dalfampridine, Placebo drug, STDP stimulation - Spinal Cord Injury
Early Phase 1CompletedShirley Ryan AbilityLab262022-06-302026-06-03
Transdermal Administration by a Novel Wireless Iontophoresis Device
Combination of Neostigmine and Glycopyrrolate, I-Box by Dynatronics - Spinal Cord Injuries, Constipation
Early Phase 1CompletedJames J. Peters Veterans Affairs Medical Center22022-03-222025-09-17
Spinal Cord Associative Plasticity Study
Non-invasive pairing of cortical and spinal stimulation, Intraoperative pairing of cortical and spinal stimulation, Non-invasive repeated pairing of cortical and spinal stimulation (SCAP) - Cervical Spinal Cord Injury, Tetraplegia/Tetraparesis
Early Phase 1RecruitingColumbia University922021-09-102026-06-18
Combining Wearable Robotic Orthosis With Visual and Haptic Feedback to Enhance the Recovery of Upper Extremity Motor Function and ADL in Persons With Acute SCI
MyoMo orthosis and VR games, MyoPro robot only, Games only - SCI - Spinal Cord Injury
Early Phase 1UnknownKessler Foundation202021-04-012023-05-06
Chronic Transcutaneous Stimulation to Promote Motor Function and Recovery in Individuals With Paralysis or Paresis
Transcutaneous Electrical Stimulation - Healthy Volunteers, Spinal Cord Injury
Early Phase 1RecruitingNorthwell Health642020-12-022026-03-11
Brain Activity in People With Chronic Neuropathic Pain and Spinal Cord Injury
Neurofeedback - Neuropathic Pain, Spinal Cord Injury
Early Phase 1UnknownKessler Foundation302020-08-012021-11-12
Pharmacokinetics of Neostigmine and Glycopyrrolate
Combination of Neostigmine and Glycopyrrolate, I-Box by Dynatronics - Spinal Cord Injuries, Constipation
Early Phase 1CompletedJames J. Peters Veterans Affairs Medical Center132020-03-092025-09-17

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Paralysis (4)  ·  Urinary Bladder, Neurogenic (4)  ·  Hypoxia (3)  ·  Neurogenic Bowel (3)  ·  Quadriplegia (3)  ·  Constipation (2)  ·  Encopresis (2)  ·  Fecal Incontinence (2)  ·  Stroke (2)  ·  Urinary Tract Infections (2)  ·  Autonomic Dysreflexia (1)  ·  Disease (1)  ·  Hyperoxia (1)  ·  Multiple Sclerosis (1)

Broader conditions

Central Nervous System Diseases (28)  ·  Nervous System Diseases (28)  ·  Wounds and Injuries (28)  ·  Spinal Cord Diseases (27)  ·  Trauma, Nervous System (27)  ·  Pathological Conditions, Signs and Symptoms (18)  ·  Signs and Symptoms (18)  ·  Neurologic Manifestations (12)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Male Urogenital Diseases (4)  ·  Urinary Bladder Diseases (4)  ·  Urogenital Diseases (4)  ·  Urologic Diseases (4)  ·  Colonic Diseases (3)

Interventions

Exercise (3)  ·  Glycopyrrolate (3)  ·  Iontophoresis (2)  ·  4-Aminopyridine (1)  ·  APF protein, Lactobacillus crispatus (1)  ·  Baclofen (1)  ·  Botulinum Toxins, Type A (1)  ·  Buspirone (1)  ·  Cycloserine (1)  ·  Gentamicins (1)  ·  Injections (1)  ·  Neostigmine (1)  ·  Neurofeedback (1)  ·  Oxygen (1)  ·  SREBP cleavage-activating protein (1)

Sponsors

James J. Peters Veterans Affairs Medical Center (3)  ·  Kessler Foundation (3)  ·  VA Office of Research and Development (3)  ·  Medstar Health Research Institute (2)  ·  Northwell Health (2)  ·  Shirley Ryan AbilityLab (2)  ·  California State University, San Marcos (1)  ·  Cell Therapy LLC (1)  ·  Columbia University (1)  ·  Medical University of South Carolina (1)  ·  NHS Greater Glasgow and Clyde (1)  ·  The Medical Pavilion Bahamas (1)  ·  The University of Texas Health Science Center at San Antonio (1)  ·  Third Affiliated Hospital, Sun Yat-Sen University (1)  ·  University of Alberta (1)

Countries

United States (23)  ·  Canada (2)  ·  United Kingdom (1)

Top investigators

Chad E Bouton, MS (2)  ·  Christopher P Cardozo, MD (2)  ·  Alexander V Ovechkin, PhD (1)  ·  Allison Lewis, DPT, PhD (1)  ·  Amanda Garver, DO (1)  ·  Claire C Yang, MD (1)  ·  Conville S Brown, MD (1)  ·  Dennis Bourbeau, PhD (1)  ·  Jacob A Goldsmith, PhD (1)  ·  Jason B Carmel, M.D., Ph.D. (1)  ·  Jaynie Yang (1)  ·  Mariel A Purcell, MB CHB BAO (1)  ·  Mark A Korsten, MD (1)  ·  Martin Oudega, PhD (1)

Results publications

PMID 17018133, PMID 25690170, PMID 27217525, PMID 29854349, PMID 31160817, PMID 31173196, PMID 31728042, PMID 32090458, PMID 32232108, PMID 32864392, PMID 33311711, PMID 33830898, PMID 34302696, PMID 35545146, PMID 39603465, PMID 39706629, PMID 41707124

NIH funding

1IK1RX005028-01 (1), K99HD117041 (1), R01NS102920 (1), R01NS124224 (1), R35NS122336 (1)